A. Adamis

Molecular Biology · 2002–2016

A researcher in the Science corpus: 10 papers; trusts 8 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom A. Adamis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Ferrara
  2. David M. Brown
  3. Rakesh K. Jain
  4. H. Gerber

Who trusts A. Adamis overall

  1. N. Ferrara
  2. R. Apte
  3. K. Eng

Papers from A. Adamis's perspective

Ordered by how strongly the researchers A. Adamis trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
  2. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (Nature reviews. Molecular cell biology)
  3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. (New England Journal of Medicine)
  4. Tumor angiogenesis (Advances in Cancer Research)
  5. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. (Journal of Clinical Investigation)
  6. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. (Journal of Clinical Investigation)
  7. Molecular regulation of vessel maturation (Nature Medicine)
  8. Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. (Cancer Research)
  9. VEGF-Trap: A VEGF blocker with potent antitumor effects (Proceedings of the National Academy of Sciences of the United States of America)
  10. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (Cancer Research)

Their papers